New Feature: Search Alerts are available now.
Learn more
.
Skip to main content
Create Account
About PLI PLUS
Help
Contact Us
Questions? Comments?
Contact us.
Email:
PLUS@pli.edu
Phone:
877.900.5291
PLI.edu
SIGN IN
Search
Browse
All Content
Books
- Answer Books
- Course Handbooks
- Journals
- News
- Treatises
Forms
Transcripts
My Bookshelf
My History
< Back To Results
1 in 1 results
Previous Result
Next Result
Health Care and Life Sciences Law 2013
Chair(s):
Karen S. Lovitch, Scott D. Danzis
Practice Area:
Health Care
Published:
Oct 2013
ISBN:
9781402420849
PLI Item #:
42375
CHB Spine #:
M4
This version is not current.
Click here for the most recent version.
Email
Print
Add To Bookshelf
Permalink
Table of Contents
Related Items
Select All
Front Matter
Faculty Bios
Table of Contents
Chapter 1. Draft Guidance for Industry and Food and Drug Administration Staff: Mobile Medical Applications (July 21, 2011)
Chapter 2. Rethinking the FDA’s Regulation of Mobile Medical Apps
Chapter 3. FDA Issues Draft Guidance Regarding Research Use Only and Investigational Use Only in Vitro Diagnostic Products (June 13, 2011)
Chapter 4. CMS Publishes Final Sunshine Act Rule Creating New Regulatory Landscape for Physician-Manufacturer Interactions
Chapter 5. Second Circuit Recognizes Significant First Amendment Protections for Off-Label Promotion
Chapter 6. Guidance for Industry: Responding to Unsolicited Requests for Off-Label Information about Prescription Drugs and Medical Devices (December 2011)
Chapter 7. Case Analysis: The Sixth Circuit Reinforces the Holding that Only Violations of Conditions of Payment, Not Merely Conditions of Participation, Can be the Basis of a False Claims Act Action
Chapter 8. Practice Analysis: The Anticipated Impact of the Growing State FCA Trend on Businessess
Chapter 9. Health Care Sector: FCA Health Care Enforcement is White Hot
Chapter 10. Health Care Industry Current Developments: Thirty Thousand Foot View of Accountable Care Organizations and Clinical Integration
Chapter 11. Current Legal Issues Affecting the Practice of Telemedicine (July 26, 2013)
Chapter 12. Five Takeaways from the OIG’s Special Advisory Bulletin on Exclusion
Index
About Us